CLINICAL EVALUATION OF T3D-959 AS A POTENTIAL DISEASE REMEDIAL THERAPEUTIC FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
JOHN
Principal Investigator Last Name
DIDSBURY
Awardee Organization
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$686,939
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official